In 2014 the American Thoracic Society published a clinical practice guideline: the diagnosis of intensive care unit-acquired weakness in adults.
Following are its recommendations:
Recommendations to Aid in Decisions Regarding Diagnostic Testing for Intensive Care Unit-acquired Weakness (ICUAW)
Recommendation 1: The committee recommends well-designed, adequately powered and executed randomized controlled trials comparing physical rehabilitation or other alternative treatments with usual care in patients with ICUAW that measure and report patient-important outcomes. (strong recommendation)
Recommendation 2: The committee recommends clinical research to determine the role of prior patient disability in the development of and recovery from ICUAW. (strong recommendation)
Recommendation 3: The committee recommends clinical research that determines whether or not patients would want to know if they have ICUAW even though no specific therapy currently exists and how patient preferences influence medical decision making or the perception of prognosis. (strong recommendation)
To read the complete guideline click on the following link: